Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
FDA approved the first generic drug containing liraglutide in December 2024
COMING SOON: Semaglutide + B12 Semaglutide + [TBD Add your option here] This section will be available soon stay tuned
In a more fragile world, where geopolitical instability has the potential to cause knock-on effects for commercial activities, Stevanato Groups highly integrated service offering and global reach can provide greater control and introduce higher levels of efficiency and continuity of supply throughout the supply chain, from sourcing raw materials through to the robust production of patient-friendly autoinjectors and pen injectors that are fully compliant with current regulatory requirements
The trial is registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000011118)
